Notice Number: NOT-OD-20-068
Release Date: February 05, 2020
Office of The Director, National Institutes of Health (OD)
This Notice provides guidance about the NIH Fiscal Operations for FY 2020 and implements The Further Consolidated Appropriations Act, 2020 (Public Law 116-94), signed into law on December 20, 2019. With the passage of the Act, NIH received a 5.9 percent increase over FY 2019 Enacted, for a total of $41.64 billion in program level funding including $492,000,000 authorized under the 21st Century Cures Act and specific increases for Alzheimer’s disease, All of Us, the BRAIN Initiative, and the Childhood Cancer Data Initiative. The mandatory funding for Type 1 Diabetes provided in PL 116-94 through May 22, 2020, is $96.58 million.
The following NIH fiscal policies are instituted in FY 2020:
FY 2020 Funding Levels: Non-competing continuation awards made in FY 2020 will generally be issued at the commitment level indicated on the Notice of Award. Any exceptions will be posted at the site listed under "Additional Information" below. Subsequent budget periods are funded based on the availability of appropriations, satisfactory performance, compliance with the terms and conditions of the award, and the continued best interest of the Federal government .The NIH awarding Institutes/Centers (IC) will develop and post their fiscal policies consistent with overall NIH goals and available FY 2020 funds.
Ruth L. Kirschstein National Research Service Awards (NRSA): Consistent with the recommendations of the Advisory Committee to the Director regarding the Biomedical Research Workforce, the NIH will increase NRSA stipends by approximately 2 percent for predocs and 4-5 percent on average for postdocs. The full range of stipend adjustments for FY 2020 will be published in a separate notice that will be released soon.
Next Generation Researchers Initiative Policy: NIH will prioritize meritorious R01- equivalent applications from ESI PD/PIs. By providing funding priority for ESIs, NIH intends to encourage funding applications that involve researchers earlier in their career in accordance with the policy established in FY 2017 and described at https://grants.nih.gov/grants/guide/notice-files/NOT-OD-17-101.html.
Salary Limits: Section 202 of the The Further Consolidated Appropriations Act, 2020 prohibits payments for salaries under grants and other extramural mechanisms in excess of Executive Level II currently set at $197,300.
Other Legislative Mandates: Other statutory requirements are described in NOT-OD-20-066
Additional Information: Additional details on Fiscal Operations, including specific funding strategies for ICs will be posted at https://grants.nih.gov/grants/financial/index.htm.
Please direct all inquiries to:
Division of Grants Policy
National Institutes of Health